{"DataElement":{"publicId":"2974055","version":"1","preferredName":"Disease or Disorder International Neuroblastoma Staging System Stage","preferredDefinition":"A description of the International Neuroblastoma Staging System disease stage.","longName":"2512861v1.0:2974047v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2512861","version":"1","preferredName":"Disease or Disorder Status","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.","longName":"2404658v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898979-184A-3A90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2974047","version":"1","preferredName":"International Neuroblastoma Staging System Stage","preferredDefinition":"A surgicopathological staging system for neuroblastoma, based on the Evans staging system._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"2974047v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD162ED-31A6-CB7C-E040-BB89AD43261E","beginDate":"2009-12-28","endDate":null,"createdBy":"SORENSENS","dateCreated":"2011-02-21","modifiedBy":"ONEDATA","dateModified":"2011-02-21","deletedIndicator":"No"},{"value":"Stage 1","valueDescription":"Stage 1 Neuroblastoma","ValueMeaning":{"publicId":"3553537","version":"1","preferredName":"Stage 1 Neuroblastoma","longName":"3553537","preferredDefinition":"Localized tumor with complete gross excision, with or without microscopic residual disease; representative ipsilateral lymph nodes negative for tumor microscopically. (cancer.gov)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 1 Neuroblastoma","conceptCode":"C6638","definition":"Localized tumor with complete gross excision, with or without microscopic residual disease; representative ipsilateral lymph nodes negative for tumor microscopically. (cancer.gov)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6E8B1F1-80A4-3E15-E040-BB89AD437211","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6E8B1F1-80BD-3E15-E040-BB89AD437211","beginDate":"2009-12-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","deletedIndicator":"No"},{"value":"Stage 2A","valueDescription":"Stage 2A Neuroblastoma","ValueMeaning":{"publicId":"3553538","version":"1","preferredName":"Stage 2A Neuroblastoma","longName":"3553538","preferredDefinition":"Localized tumor with incomplete gross excision; representative ipsilateral nonadherent lymph nodes negative for tumor microscopically. (cancer.gov)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 2A Neuroblastoma","conceptCode":"C102845","definition":"Localized tumor with incomplete gross excision; representative ipsilateral nonadherent lymph nodes negative for tumor microscopically. (cancer.gov)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6E8B1F1-80C9-3E15-E040-BB89AD437211","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6E8B1F1-80E2-3E15-E040-BB89AD437211","beginDate":"2009-12-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","deletedIndicator":"No"},{"value":"Stage 2B","valueDescription":"Stage 2B Neuroblastoma","ValueMeaning":{"publicId":"3553539","version":"1","preferredName":"Stage 2B Neuroblastoma","longName":"3553539","preferredDefinition":"Localized tumor with or without complete gross excision, with ipsilateral nonadherent lymph nodes positive for tumor. Enlarged contralateral lymph nodes must be negative microscopically. (cancer.gov)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 2B Neuroblastoma","conceptCode":"C102846","definition":"Localized tumor with or without complete gross excision, with ipsilateral nonadherent lymph nodes positive for tumor. Enlarged contralateral lymph nodes must be negative microscopically. (cancer.gov)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6E8B1F1-80EE-3E15-E040-BB89AD437211","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6E8B1F1-8107-3E15-E040-BB89AD437211","beginDate":"2009-12-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","deletedIndicator":"No"},{"value":"Stage 3","valueDescription":"Stage 3 Neuroblastoma","ValueMeaning":{"publicId":"3553540","version":"1","preferredName":"Stage 3 Neuroblastoma","longName":"3553540","preferredDefinition":"Unresectable unilateral tumor infiltrating across the midline, with or without regional lymph node involvement; or localized unilateral tumor with contralateral regional lymph node involvement; or midline tumor with bilateral extension by infiltration (unresectable) or by lymph node involvement. The midline is defined as the vertebral column. Tumors originating on one side and crossing the midline must infiltrate to or beyond the opposite side of the vertebral column. (cancer.gov)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 3 Neuroblastoma","conceptCode":"C6640","definition":"Unresectable unilateral tumor infiltrating across the midline, with or without regional lymph node involvement; or localized unilateral tumor with contralateral regional lymph node involvement; or midline tumor with bilateral extension by infiltration (unresectable) or by lymph node involvement. The midline is defined as the vertebral column. Tumors originating on one side and crossing the midline must infiltrate to or beyond the opposite side of the vertebral column. (cancer.gov)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6E8B1F1-8113-3E15-E040-BB89AD437211","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6E8B1F1-812C-3E15-E040-BB89AD437211","beginDate":"2009-12-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","deletedIndicator":"No"},{"value":"Stage 4","valueDescription":"Stage 4 Neuroblastoma","ValueMeaning":{"publicId":"3553541","version":"1","preferredName":"Stage 4 Neuroblastoma","longName":"3553541","preferredDefinition":"Any primary tumor with dissemination to distant lymph nodes, bone, bone marrow, liver, skin, and/or other organs, except as defined for stage 4S. (cancer.gov)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 4 Neuroblastoma","conceptCode":"C6641","definition":"Any primary tumor with dissemination to distant lymph nodes, bone, bone marrow, liver, skin, and/or other organs, except as defined for stage 4S. (cancer.gov)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6E8B1F1-8138-3E15-E040-BB89AD437211","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6E8B1F1-8151-3E15-E040-BB89AD437211","beginDate":"2009-12-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","deletedIndicator":"No"},{"value":"Stage 4S","valueDescription":"Stage 4S Neuroblastoma","ValueMeaning":{"publicId":"3553542","version":"1","preferredName":"Stage 4S Neuroblastoma","longName":"3553542","preferredDefinition":"Localized primary tumor, as defined for stage 1, 2A, or 2B, with dissemination limited to skin, liver, and/or bone marrow (limited to infants younger than 1 year). Marrow involvement should be minimal (i.e., <10% of total nucleated cells identified as malignant by bone biopsy or by bone marrow aspirate). More extensive bone marrow involvement would be considered stage 4 disease. The results of the MIBG scan, if performed, should be negative for disease in the bone marrow. (cancer.gov)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 4S Neuroblastoma","conceptCode":"C9504","definition":"Localized primary tumor, as defined for stage 1, 2A, or 2B, with dissemination limited to skin, liver, and/or bone marrow (limited to infants younger than 1 year). Marrow involvement should be minimal (i.e., <10% of total nucleated cells identified as malignant by bone biopsy or by bone marrow aspirate). More extensive bone marrow involvement would be considered stage 4 disease. The results of the MIBG scan, if performed, should be negative for disease in the bone marrow. (cancer.gov)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6E8B1F1-815D-3E15-E040-BB89AD437211","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6E8B1F1-8176-3E15-E040-BB89AD437211","beginDate":"2009-12-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3553592","version":"1","preferredName":"International Neuroblastoma Staging System Stage","preferredDefinition":"A surgicopathological staging system for neuroblastoma, based on the Evans staging system.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C85416:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Neuroblastoma Staging System","conceptCode":"C85416","definition":"A surgicopathological staging system for neuroblastoma, based on the Evans staging system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EB34CD-B8BC-D87E-E040-BB89AD436229","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCDCEC7-EB17-F214-E040-BB89AD435B1B","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"KUMMEROA","dateModified":"2012-08-10","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964894","version":"1","longName":"2026r1: Neuroblastoma Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964916","version":"1","longName":"2126r1: Neuroblastoma Post-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650574","version":"1","longName":"NBL","context":"OCG"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"neu_base_inss_dx_stg_diag","type":"NMDP_FN","context":"NHLBI"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"INSS_Stage","type":"COG GDE Short Name","context":"CTEP"},{"name":"PerformedClinicalInterpretation:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Specify the International Neu","type":"Preferred Question Text","description":"Specify the International Neuroblastoma Staging System disease stage:","url":null,"context":"NHLBI"},{"name":"TARGET Question Text","type":"Alternate Question Text","description":"INSS Stage","url":null,"context":"NCIP"},{"name":"BRIDG mapping for CDE:2974055","type":"BRIDG Mapping Path","description":"PerformedDiagnosis > AssessedResultRelationship > PerformedObservation > PerformedClinicalInterpretation.value(ANY=>CD).code WHERE PerformedDiagnosis.value = \"Neuroblastoma\" AND PerformedClinicalInterpretation.value(ANY=>CD).codingSystem = \"International Neuroblastoma Staging System\" AND AssessedResultRelationship.typeCode = \"staging\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCDCEC7-EC07-F214-E040-BB89AD435B1B","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"KUMMEROA","dateModified":"2021-08-17","changeDescription":". 2021-8-17 ak System generated def displayed as alt def. 1/9/14mn-added Bridg info.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}